[1] |
Hai-feng LI.
Glucocorticoids remain the basis for treatment of myasthenia gravis in the era of targeted therapies
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2024, 24(5): 295-307.
|
[2] |
LI Hai-feng, HUANG Yu, CHEN Xiang-jun.
Establishment of common data element for myasthenia gravis and its significance in the researches of phenotypes
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2020, 20(1): 34-47.
|
[3] |
LI Ting, YANG Li.
Progress in rituximab for anti-MuSK antibody-related myasthenia gravis
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2020, 20(1): 48-54.
|
[4] |
CAO Shan, HAO Hong-jun, LIU Yong-gang, REN Cui-jian, XU Yun-he, ZHAO Xiao-mei, ZHAO Jing.
Anti-MuSK antibody positive myasthenia gravis with Graves disease: one case report
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2019, 19(2): 137-140.
|
[5] |
JIANG Jian-hua, XUE Qun, LIU Cui-ping, FANG Qi, YU Li-qiang, ZHANG Lu-lu, JIANG Jue-an.
Changes of B cell subsets characterized with CD27 and CD38 phenotypes in peripheral blood of myasthenia gravis patients
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2019, 19(11): 883-890.
|
[6] |
GAO Yu-han, JIN Hai-qiang, HAO Hong-jun, SUN Yong-an, GAO Feng.
Study of circulating Th17 cells and associated cytokines in myasthenia gravis
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2019, 19(10): 780-785.
|
[7] |
CHU Shan-shan, CHEN Deng, ZHU Li-na, TAN Ge, XU Da, WANG Hai-jiao, ZHANG Yu, LIU Ling.
Efficacy and safety of rituximab in the treatment of refractory myasthenia gravis: Meta-analysis
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2018, 18(7): 494-500.
|
[8] |
LIANG Fu-ru, ZHANG Tian-you, YAO Gui-juan, JIA Yan-hong, LI Jing, LIU Guo-rong.
Comparative study on the value of accessory examinations in the diagnosis of ocular myasthenia gravis
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2016, 16(10): 684-688.
|
[9] |
LIU Yun, LIU Ran, HAO Hong-jun, ZHAO Gui-ping, GAO Feng.
Detection and clinical significance of serum autoantibodies in patients with myasthenia gravis
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2016, 16(10): 678-683.
|
[10] |
YU Xiao-long, LIANG Bing, YUE Yao-xian, ZHANG Xu, XIE Yan-chen, ZHANG Xian-jun, GU Chuan-kai, SONG Min, DING Xiao-jun, HAO Hong-jun, LI Hai-feng.
Association analysis between IL-2Rβ gene polymorphism and myasthenia gravis
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2016, 16(10): 670-677.
|
[11] |
LIU Yin-hong, HOU Shi-fang.
Neuroelectrophysiological studies on neurological autoimmune diseases
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2014, 14(9): 757-763.
|
[12] |
WANG Ying-peng, CHEN Ping, LI Zun-bo, ZHANG Jun, YUAN Dan, ZHEN Wei-lan, ZENG Qing-hong, GONG Zhong, LIU Jian-jun, SHEN Ding-guo.
Clinical features and risk factors for myasthenia gravis crisis after impact therapy of glucocorticoid
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2014, 14(10): 883-888.
|
[13] |
HUANG Ling, WANG Lei, YIN Shi-min, WANG Jia-nan, CHEN Hong, ZHANG Hong-li, YUAN Li.
Clinical evaluation of cyclophosphamide therapy in patients with myasthenia gravis and thymoma
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2014, 14(10): 878-882.
|
[14] |
WANG Li-li, ZHANG Yun, HE Mao-lin, XU Xian-hao.
Clinical characteristics of patients with myasthenia gravis associated with other autoimmune diseases
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2014, 14(10): 873-877.
|
[15] |
FU Yu, TENG Yin-yan, XU Chao-wei, ZHANG Xu.
The effect of bone marrow stem cells on the treatment of experimental autoimmune myasthenia gravis rat
[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2012, 12(2): 161-165.
|